[go: up one dir, main page]

BRPI0520568B8 - uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv - Google Patents

uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv

Info

Publication number
BRPI0520568B8
BRPI0520568B8 BRPI0520568A BRPI0520568A BRPI0520568B8 BR PI0520568 B8 BRPI0520568 B8 BR PI0520568B8 BR PI0520568 A BRPI0520568 A BR PI0520568A BR PI0520568 A BRPI0520568 A BR PI0520568A BR PI0520568 B8 BRPI0520568 B8 BR PI0520568B8
Authority
BR
Brazil
Prior art keywords
drugs
preparation
cell wall
wall skeleton
hpv infection
Prior art date
Application number
BRPI0520568A
Other languages
English (en)
Inventor
Zhang Ce
Zhang Guoying
Zhao Jian
Hong Xiaoming
Zhang Yi
Original Assignee
Liaoning Greatest Bio Pharmaceutical Co Ltd
Liaoning Nakejia Biopharmaceutical Co Ltd
Shenyang Sun Bell Com Biopharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liaoning Greatest Bio Pharmaceutical Co Ltd, Liaoning Nakejia Biopharmaceutical Co Ltd, Shenyang Sun Bell Com Biopharmaceutical Co Ltd filed Critical Liaoning Greatest Bio Pharmaceutical Co Ltd
Publication of BRPI0520568A2 publication Critical patent/BRPI0520568A2/pt
Publication of BRPI0520568B1 publication Critical patent/BRPI0520568B1/pt
Publication of BRPI0520568B8 publication Critical patent/BRPI0520568B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv. a presente invenção refere-se ao uso de esqueleto de parede celular de nocardia rubra, especialmente o novo uso do mesmo na preparação de medicamentos anti-hpv.
BRPI0520568A 2005-09-23 2005-11-23 uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv BRPI0520568B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2005101055337A CN1935262B (zh) 2005-09-23 2005-09-23 红色诺卡氏菌细胞壁骨架在制备抗人乳头瘤病毒药物的用途
CN200510105533.7 2005-09-23
PCT/CN2005/001977 WO2007033533A1 (en) 2005-09-23 2005-11-23 Use of nocardia rubra cell wall skeleton to produce medicaments for resisting human papilloma virus hpv

Publications (3)

Publication Number Publication Date
BRPI0520568A2 BRPI0520568A2 (pt) 2009-05-19
BRPI0520568B1 BRPI0520568B1 (pt) 2019-10-08
BRPI0520568B8 true BRPI0520568B8 (pt) 2021-05-25

Family

ID=37888528

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520568A BRPI0520568B8 (pt) 2005-09-23 2005-11-23 uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv

Country Status (8)

Country Link
US (1) US8460722B2 (pt)
EP (1) EP1938826B1 (pt)
JP (1) JP4854742B2 (pt)
KR (1) KR20080048542A (pt)
CN (1) CN1935262B (pt)
BR (1) BRPI0520568B8 (pt)
RU (1) RU2394586C2 (pt)
WO (1) WO2007033533A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526119A (zh) * 2010-12-23 2012-07-04 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架增强树突状细胞功能的方法
CN116898881A (zh) * 2017-01-11 2023-10-20 福建省山河药业有限公司 红色诺卡氏菌细胞壁骨架在制备治疗痤疮的药物/护肤品中的用途及其药物/护肤品组合物
WO2020147472A1 (zh) * 2019-01-15 2020-07-23 辽宁格瑞仕特生物制药有限公司 赤红球菌产品及其制药用途
CN112040962A (zh) * 2019-03-14 2020-12-04 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗外阴白色病变中的用途
KR20220004092A (ko) 2019-04-24 2022-01-11 랴오닝 그레이티스트 바이오-파마슈티컬 컴퍼니 리미티드 온열 손상 치료에서의 노카르디아 루브라 세포벽 골격의 용도
EP4056682A4 (en) 2020-01-21 2023-01-18 Liaoning Greatest Bio-Pharmaceutical Co., Ltd. USE OF THE CELL WALL SKELETON OF NOCARDIA RUBRA IN REGENERATIVE MEDICINE
CN115025128A (zh) * 2022-06-24 2022-09-09 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗宫颈病变中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
CN1094288A (zh) * 1993-04-23 1994-11-02 福建省微生物研究所 利用红色诺卡氏菌制造细胞壁骨架粉末的方法
US7273602B2 (en) * 2001-07-19 2007-09-25 Akira Hayashi Immunotherapy for humans
CN1291725C (zh) * 2002-03-08 2006-12-27 沈阳胜宝康生物制药有限公司 用于治疗宫颈糜烂的红色诺卡氏菌细胞壁骨架制剂及其制法
SI1534330T1 (sl) * 2002-09-06 2014-08-29 Ucl Business Plc Cele bakterijske celice kot imunomodulatorji
WO2005023277A1 (fr) 2003-09-05 2005-03-17 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. Composition a la base de squelettes de parois de cellules de nocardia rouge procede de preparation et son utilisation therapeutique pour traiter l'erosion cervicale
CN1879661B (zh) 2005-06-16 2012-06-20 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备抗真菌感染的药物中的用途
CN101073583A (zh) * 2006-05-19 2007-11-21 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备药物中的用途

Also Published As

Publication number Publication date
CN1935262B (zh) 2010-12-29
JP4854742B2 (ja) 2012-01-18
BRPI0520568B1 (pt) 2019-10-08
BRPI0520568A2 (pt) 2009-05-19
CN1935262A (zh) 2007-03-28
US20090028973A1 (en) 2009-01-29
JP2009508883A (ja) 2009-03-05
HK1100533A1 (en) 2007-09-21
EP1938826A4 (en) 2011-09-07
EP1938826A1 (en) 2008-07-02
US8460722B2 (en) 2013-06-11
WO2007033533A1 (en) 2007-03-29
RU2394586C2 (ru) 2010-07-20
EP1938826B1 (en) 2014-11-12
RU2008109165A (ru) 2009-10-27
KR20080048542A (ko) 2008-06-02

Similar Documents

Publication Publication Date Title
ECSP099044A (es) Compuestos de pirimido fusionados
MX2010004576A (es) Derivados de pirimidina novedosos.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
BRPI0819869A2 (pt) processo para a produção de um mosto de cervejeiro, uso de um processo, mosto, e, mistura de enzimas.
BRPI0819936A2 (pt) Preparação farmacêutica, método para produzir células dendríticas, células dendríticas, composição farmacêutica, e, uso de uma célula dendrítica ou uma preparação.
ECSP077271A (es) Derivados de pirimidina
DOP2011000176A (es) Compuestos organicos
AR052404A1 (es) Hidratos y polimorfos de 4-(((7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-2-pteridinil)amino)-3- metoxi-n-(1-metil-4-piperidinil)-benzamida, procedimiento para su preparacion y su uso como farmaco
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
ECSP077259A (es) Derivados de pirimidina
CL2008001951A1 (es) Compuestos derivados de imidazo[1,2-a]pirimidin-2-ilmetil sustituidos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el trastorno del sueno, depresion, ansiedad, trastorno relacionado con el abuso de sustancias, entre otras.
TW200635938A (en) Fluorosurfactants
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
DOP2011000171A (es) Compuestos organico
CL2007002377A1 (es) Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
BRPI0814420A2 (pt) composição, e, uso de álcool alcoxilado.
CL2008003712A1 (es) Compuestos derivados de tiadiazololoxifenilamidina o tiazoliloxifenilamidina; su procedimiento de preparacion; uso y procedimiento para combatir microorganismos no deseados; agente que comprende a dichos compuestos; compuestos intermediarios; y su procedimiento de preparacion.
CL2006001266A1 (es) Formas solidas cristalinas i, ii, iii, iv y v de tigeciclina; procedimiento de preparacion de las formas cristalinas ii, iv y v; composicion farmaceutica que comprende las formas cristalinas; y su uso para tratar infecciones bacterianas.
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
HN2006009000A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
BRPI0520206B8 (pt) protetor para incontinência masculina
WO2008073863A3 (en) Preparation and utility of substituted allylamines

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD. (CN) ; LIAONING NAKEJIA BIOPHARMACEUTICAL CO., LTD. (CN)

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD.

B25G Requested change of headquarter approved

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD.

B25D Requested change of name of applicant approved

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25K Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Owner name: LIAONING GREATEST BIO-PHARMACEUTICAL CO., LTD. (CN

Free format text: RETIFICADO O DESPACHO 25.4 PUBLICADO NA RPI 2508 DE 29/01/2019 SOB O ITEM (71).

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/11/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF